CapsoVision, Inc. CV
Set alert
6.73 USD -0.10 -1.46%
At close · Nov 2
6.73 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
6.70 Day range 7.01
4.50 52-week range 15.37
- YTD
- -37.04%
- 1 year
- +37.91%
- Open
- 6.91
- Prev close
- 6.83
- Mkt cap
- 358.11M
- Vol
- 104.48K
- Avg vol
- 165.77K
- EPS
- -0.45
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.70
- High
- 7.01
YTD chart
Signals (55)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 2026 | 7 hours ago |
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| MACD: Buy Signal | Oct 5, 2026 | 4 weeks ago |
| MACD: Sell Signal | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 4, 2026 | 1 month ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| SMA: Bearish | Jul 23, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jul 17, 2026 | 3 months ago |
| SMA: Bearish | Jul 7, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 6, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| SMA: Bearish | Jun 16, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 16, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 5 months ago |
| SMA: Bullish | May 29, 2026 | 5 months ago |
| SMA: Bearish | May 28, 2026 | 5 months ago |
| SMA: Bullish | May 27, 2026 | 5 months ago |
| SMA: Bearish | May 22, 2026 | 5 months ago |
| SMA: Bullish | May 21, 2026 | 5 months ago |
| SMA: Bearish | May 15, 2026 | 5 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 28, 2026 | 6 months ago |
| SMA: Bullish | Apr 24, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 17, 2026 | 6 months ago |
| SMA: Bearish | Apr 16, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 6, 2026 | 7 months ago |
| RSI: Overbought | Mar 23, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 6, 2026 | 8 months ago |
| SMA: Bearish | Jan 7, 2026 | 9 months ago |
Financials — quick view
CV Revenue — quarterly 3.64M
CV Net income — quarterly -7.48M
CV EPS — quarterly -0.15
News
- CapsoVision to Release Third Quarter 2026 Financial Results on November 12, 2026
- CapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer Screening
- SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
- CapsoVision to Present at the 20th Annual LD Micro Main Event
- New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease
- Head to Head Survey: CapsoVision (NASDAQ:CV) vs. Brainsway (NASDAQ:BWAY)
- CapsoVision (NASDAQ:CV) and NeuroPace (NASDAQ:NPCE) Critical Contrast
- AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress
- CapsoVision gets FDA clearance for AI Highlights
- CapsoVision Receives FDA Clearance For Its AI Highlights Reading Tool For The CapsoCam Plus System
Your note
Sign in to keep a note on CV — it syncs with the Stock Master app.